Contrasting our findings in HepG2, circCDYL pull-down was highly enriched (10×) for IGF2BP1 and IGF2BP2, indicating strong and specific circCDYL-IGF2BPs interactions in BC cells. The gene discussed is IGF2BP2; the disease is breast cancer.